‘Clayface’ Nearly Pays Off Its Budget in One Weekend, and It Might Be the Win DC Needed

DC Studios has had a bruising year at the box office, and the pressure on every new release has been impossible to miss. After a strong start with ‘Superman’, the studio’s slate hit a rough patch, and fans and analysts have been watching each opening weekend for signs of a recovery. That made the arrival of the horror-flavored ‘Clayface’ one of the most closely watched launches of the Halloween season.

The film is a different kind of bet from the studio’s earlier superhero outings. It’s an R-rated body horror story about one of Batman’s most unsettling villains, directed by James Watkins and led by Tom Rhys Harries as Matt Hagen, an actor on the verge of superstardom whose life collapses after he is disfigured. With no major stars and a modest price tag, expectations were set at solid rather than spectacular.

‘Clayface‘ has now opened with $43M worldwide, against a reported budget of $44M. That means the film is just $1M away from earning back its production cost after only 3 days in theaters. It’s the closest any DC Universe movie has come to recouping its budget in its global debut.

The haul breaks down to $24M domestically and roughly $19M internationally. Playing in 3,458 theaters, the movie narrowly edged out A24’s ‘You Can See Everything’ for first place at the domestic box office. That documentary earned $19.5M in its second weekend, which made the race for the top spot much closer than anyone predicted.

Context matters here, because by raw numbers this is the lowest global debut for any DC Universe installment. The difference is the budget. ‘Superman’ reportedly cost $225M and earned a $125M domestic opening, while ‘Supergirl’ opened to $37.1M domestically before finishing with $126.4M worldwide against a budget of $170M to $186M.

Seen that way, ‘Clayface’ is playing a very different game. A common rule of thumb says a film needs to earn roughly 2.5 times its budget to break even, which puts the horror film’s target at around $110M worldwide. That is a far more reachable bar than the one its predecessors faced.

Reviews have been mixed but generally encouraging. The film holds a Certified Fresh 75% on Rotten Tomatoes from 83 critic reviews, along with a 59 on Metacritic. That is a meaningful step up from ‘Supergirl’, which landed a rotten 57% from critics.

Opinion has been split on how far the movie pushes its horror. One early review praised Harries’ performance while calling the film forgettable, comparing it to ‘Morbius’. Others have celebrated the brutal body horror and the actor’s turn as a tragic figure, and early reactions were largely enthusiastic.

The release also says something about where the studio might be headed. Instead of another giant tentpole, DC went small, scary and relatively cheap, and it timed the movie for Halloween. The project originated with Mike Flanagan, whose take on the character was strong enough to convince James Gunn to move forward, even though Flanagan ultimately couldn’t direct it.

Not everyone is convinced the result is cause for celebration. Some fans online have argued that a $24M domestic opening is not impressive for a DC product, whatever the film cost to make. Even so, the numbers are being described as a modest, R-rated win for the studio under the stewardship of Gunn and Peter Safran.

Watch the first trailer for #Clayface. The new DC horror film is in theaters October 23. https://t.co/gqrrtJSou5

— Rotten Tomatoes 🍅 (@RottenTomatoes) April 22, 2026

The real test comes over the next few weeks. Horror films often rely on strong word of mouth, and the Halloween calendar should help the film hold on to screens. If it holds up, it could climb toward that $110M break-even mark and give DC a much-needed bit of momentum.

For a studio that has been searching for stability, a profitable mid-budget horror film could be a quieter way to rebuild confidence. It might not be the blockbuster-sized rebound some fans wanted, but it could be a smart reset.

Have something to add? Let us know in the comments!